Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Tutt, A., Tovey, H., Cheang, M.C.U. et al. (35 more authors) (2018) Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature Medicine, 24 (5). pp. 628-637. ISSN 1078-8956

Abstract

Metadata

Authors/Creators:
  • Tutt, A.
  • Tovey, H.
  • Cheang, M.C.U.
  • Kernaghan, S.
  • Kilburn, L.
  • Gazinska, P.
  • Owen, J.
  • Abraham, J.
  • Barrett, S.
  • Barrett-Lee, P.
  • Brown, R.
  • Chan, S.
  • Dowsett, M.
  • Flanagan, J.M.
  • Fox, L.
  • Grigoriadis, A.
  • Gutin, A.
  • Harper-Wynne, C.
  • Hatton, M.Q.
  • Hoadley, K.A.
  • Parikh, J.
  • Parker, P.
  • Perou, C.M.
  • Roylance, R.
  • Shah, V.
  • Shaw, A.
  • Smith, I.E.
  • Timms, K.M.
  • Wardley, A.M.
  • Wilson, G.
  • Gillett, C.
  • Lanchbury, J.S.
  • Ashworth, A.
  • Rahman, N.
  • Harries, M.
  • Ellis, P.
  • Pinder, S.E.
  • Bliss, J.M.
Copyright, Publisher and Additional Information: © 2018 Nature America Inc., part of Springer Nature. This is an author produced version of a paper subsequently published in Nature Medicine. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 2 March 2018
  • Published (online): 30 April 2018
  • Published: May 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 10 Jan 2019 11:14
Last Modified: 07 Feb 2019 09:05
Published Version: https://doi.org/10.1038/s41591-018-0009-7
Status: Published
Publisher: Nature Research
Refereed: Yes
Identification Number: https://doi.org/10.1038/s41591-018-0009-7
Related URLs:

Share / Export

Statistics